Literature DB >> 26272202

Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.

Carolina Pazin1, Andréia Moreira de Souza Mitidieri1, Ana Paula Moreira Silva1, Maria Beatriz Ferreira Gurian1, Omero Benedicto Poli-Neto1, Julio Cesar Rosa-E-Silva2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome/interstitial cystitis (BPS/IC) has various treatments; however, no standardized treatment has been established. The aim was to analyze different types of treatment of BPS/IC and their effectiveness.
METHODS: A literature review with a search strategy for articles related to BPS/IC published between 1990 and 2014 was conducted on MEDLINE, PUBMED, and SCOPUS. Only randomized controlled trials in women were included in the meta-analysis, while other experimental studies were used as bases for a systematic review of the topic. Clinical trial quality was defined according to the Jadad scale.
RESULTS: Of 356 articles, 13 were included in the analysis. The intervention methods were as follows: instillation of hyaluronic acid, botulinum toxin A, intravesical lidocaine, hyperbaric chamber, massage, physiotherapy, phosphate-buffered saline, piroxicam in combination with doxepin, and others. We did not find any treatment with at least two randomized controlled trials for meta-analysis. Among the assessment tools for symptoms of BPS/IC, the most frequently used were the visual analogue scale, voiding record, and the O'Leary-Sant questionnaire.
CONCLUSION: Existing studies were not able to define the best approach for the treatment of BPS/IC. The lack of standardized treatment may be related to the diversity of interventions used; therefore, further studies with better methodological quality are needed.

Entities:  

Keywords:  Bladder pain syndrome; Drug treatment; Interstitial cystitis; Prospective and clinical trials

Mesh:

Substances:

Year:  2015        PMID: 26272202     DOI: 10.1007/s00192-015-2815-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  64 in total

Review 1.  Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review.

Authors:  Sahithi Tirumuru; Deyaa Al-Kurdi; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2010-05-07       Impact factor: 2.894

2.  The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.

Authors:  K Peters; A Diokno; B Steinert; M Yuhico; B Mitchell; S Krohta; B Gillette; J Gonzalez
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

Review 3.  Diagnosis and treatment of interstitial cystitis in adolescents.

Authors:  J L Yoost; S P Hertweck; M Loveless
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-05-20       Impact factor: 1.814

4.  A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis.

Authors:  J J Bade; M Laseur; A Nieuwenburg; L T van der Weele; H J Mensink
Journal:  Br J Urol       Date:  1997-02

5.  Interstitial cystitis: bladder training with intravesical oxybutynin.

Authors:  G A Barbalias; E N Liatsikos; A Athanasopoulos; G Nikiforidis
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

6.  Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.

Authors:  T Ueda; M Tamaki; O Ogawa; T Yamauchi; N Yoshimura
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

Review 7.  Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis.

Authors:  Vanessa R Anderson; Caroline M Perry
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis?

Authors:  Lukas K Daha; Dara Lazar; Reiner Simak; Heinz Pflüger
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-20

Review 9.  The role of the mast cell in interstitial cystitis.

Authors:  G R Sant; T C Theoharides
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

10.  Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.

Authors:  B A O'Reilly; P L Dwyer; G Hawthorne; S Cleaver; E Thomas; A Rosamilia; M Fynes
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

View more
  8 in total

1.  Bladder pain syndrome/interstitial cystitis response to nerve blocks and trigger point injections.

Authors:  Soha Patil; Gabrielle Daniel; Yogita Tailor; Marjorie Mamsaang; Janaki Natarajan; Erika Moody; Neha James; Rakhi Vyas; Allyson Shrikhande
Journal:  BJUI Compass       Date:  2022-06-18

2.  Immunomodulation-A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?

Authors:  Björn Wullt; Daniel S C Butler; Ines Ambite; Julia Kinsolving; Christian Krintel; Catharina Svanborg
Journal:  Eur Urol Open Sci       Date:  2021-08-06

3.  Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.

Authors:  Mari Imamura; Neil W Scott; Sheila A Wallace; Joseph A Ogah; Abigail A Ford; Yann A Dubos; Miriam Brazzelli
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

Review 4.  Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis.

Authors:  Wei Zhang; Xiaojing Deng; Chunyu Liu; Xu Wang
Journal:  Int Urogynecol J       Date:  2016-09-10       Impact factor: 2.894

Review 5.  Current status of oral pentosan polysulphate in bladder pain syndrome/interstitial cystitis.

Authors:  Rajesh Taneja
Journal:  Int Urogynecol J       Date:  2020-09-07       Impact factor: 2.894

6.  Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis.

Authors:  Bingkun Li; Qu Leng; Chuanyin Li; Xiao Tan; Wei Su; Chaoming Li
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

7.  Boswellic Acids, Pentacyclic Triterpenes, Attenuate Oxidative Stress, and Bladder Tissue Damage in Cyclophosphamide-Induced Cystitis.

Authors:  Maryam Fatima; Irfan Anjum; Aamir Abdullah; Shaun Zshaan Abid; Muhammad Nasir Hayat Malik
Journal:  ACS Omega       Date:  2022-04-14

8.  Evaluation of the efficacy of Chinese herbal medicine and acupuncture for the prevention of mental disorders in interstitial cystitis patients: A nationwide population-based study.

Authors:  Hao-Hsiu Hung; Wen-Chi Chen; Yung-Hsiang Chen; Lu-Ting Chiu; Huey-Yi Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.